ℹ️ Compiled from public regulatory records · Last regulator revision: January 5, 2026🚩 Report this page
Antimony Potassium Tartrate
Active ingredient
Sold as apo-PULM · COUGHTONE · VACC HC · ANTIM TART
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 4
- FDA reports (12 mo)
- 45
Overview
Antimony Potassium Tartrate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | January 5, 2026 |
USUnited States· FDA
4 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
Sources & citations
- [1]FDA DailyMed · 19a5e8ed-2063-9f… · revised May 30, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.